Celgene appoints new EVP, general counsel

Celgene Corp. announced Wednesday it has appointed Jonathan Biller its executive vice president and general counsel, effective July 3.

Biller will be responsible for global legal strategy and will serve on the Summit-based biopharmaceutical company’s executive committee.

Biller will succeed Gerald F. Masoudi, who is leaving the company to become chief legal officer with a private company.

“Jonathan has been an integral part of Celgene’s senior management team for the last seven years. He has led our capital allocation strategy and provided industry-wide leadership on U.S. corporate tax reform. His extensive legal experience and deep understanding of Celgene enable him to immediately strengthen our leadership team as General Counsel,” said Mark J. Alles, charman and CEO of Celgene. “Jerry has made many important contributions to Celgene, and we wish him and his family all the best.”

Biller joined Celgene in 2011 and was most recently senior vice president, tax and treasury and served as treasurer. Prior to Celgene, he was at Bunge Limited as its general counsel, chief tax officer and secretary. Before that, he was at Alcon Inc. He began his legal career at Hopkins & Sutter.